Zileuton |
Zyflo |
Zileuton Zyflo Zileuton is an asthma drug. It blocks leukotriene synthesis by inhibiting 5-lipoxygenase, an enzyme of the eicosanoid synthesis pathway. Zileuton is marketed by Critical Therapeutics under the brand name Zyflo. ...
Wikipedia - [full article]
Zileuton Clinical Trials
- Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne Vulgaris
ClinicalTrials.gov Identifier: NCT00098358 - Active, not recruiting
Acne Vulgaris
- Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia
ClinicalTrials.gov Identifier: NCT00056004 - Active, not recruiting
Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Lung Cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer
- Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00070486 - Active, not recruiting
stage IV non-small cell lung cancer; Adenocarcinoma of the Lung; Squamous Cell Lung Cancer; large cell lung cancer; ...
- Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis
ClinicalTrials.gov Identifier: NCT00262405 - Active, not recruiting
Idiopathic Pulmonary Fibrosis
- A Randomized, Double-Blind, Placebo Controlled Study of Zileuton CR Versus Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS
ClinicalTrials.gov Identifier: NCT00486343 - Recruiting
Asthma
- Assessment of PFT, Safety, and PK of Zileuton Injection in Asthma Patients
ClinicalTrials.gov Identifier: NCT00534625 - Not yet recruiting
Asthma
- Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study)
ClinicalTrials.gov Identifier: NCT00493974 - Recruiting
Pulmonary Disease, Chronic Obstructive
- Zileuton and Exhaled Nitric Oxide in Asthmatics
ClinicalTrials.gov Identifier: NCT00575861 - Completed
Asthma
- Safety Study of Zileuton Injection in Patients With Asthma
ClinicalTrials.gov Identifier: NCT00299065 - Completed
Asthma

Not Signed In -


